BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 38300390)

  • 21. Significance of Gut Microbiota and Short-Chain Fatty Acids in Heart Failure.
    Zhao P; Zhao S; Tian J; Liu X
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
    Belli M; Barone L; Longo S; Prandi FR; Lecis D; Mollace R; Margonato D; Muscoli S; Sergi D; Federici M; BarillĂ  F
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut Microbiota and Heart, Vascular Injury.
    Zeng C; Tan H
    Adv Exp Med Biol; 2020; 1238():107-141. PubMed ID: 32323183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Research on the Pathogenesis of NAFLD/NASH and the Gut-Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome.
    Kobayashi T; Iwaki M; Nakajima A; Nogami A; Yoneda M
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.
    Luqman A; Hassan A; Ullah M; Naseem S; Ullah M; Zhang L; Din AU; Ullah K; Ahmad W; Wang G
    Front Immunol; 2024; 15():1321395. PubMed ID: 38343539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbial metabolites and heart failure: Friends or enemies?
    Lu X; Liu J; Zhou B; Wang S; Liu Z; Mei F; Luo J; Cui Y
    Front Microbiol; 2022; 13():956516. PubMed ID: 36046023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on gut microbiota in cardiovascular diseases.
    Qian B; Zhang K; Li Y; Sun K
    Front Cell Infect Microbiol; 2022; 12():1059349. PubMed ID: 36439214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The gut microbiota and its interactions with cardiovascular disease.
    Xu H; Wang X; Feng W; Liu Q; Zhou S; Liu Q; Cai L
    Microb Biotechnol; 2020 May; 13(3):637-656. PubMed ID: 31984651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible Role of Gut Microbiota Alterations in Myocardial Fibrosis and Burden of Heart Failure in Hypertensive Heart Disease.
    Pitt B; Diez J
    Hypertension; 2024 Jul; 81(7):1467-1476. PubMed ID: 38716665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diet-Induced Gut Dysbiosis and Leaky Gut Syndrome.
    Chae YR; Lee YR; Kim YS; Park HY
    J Microbiol Biotechnol; 2024 Apr; 34(4):747-756. PubMed ID: 38321650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbiome and its role in cardiovascular diseases.
    Ahmadmehrabi S; Tang WHW
    Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of splanchnic congestion and the intestinal microenvironment in the pathogenesis of advanced heart failure.
    Polsinelli VB; Marteau L; Shah SJ
    Curr Opin Support Palliat Care; 2019 Mar; 13(1):24-30. PubMed ID: 30640740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Concept of a Heart-Gut Axis in the Pathophysiology of Heart Failure.
    Kamo T; Akazawa H; Suzuki JI; Komuro I
    Korean Circ J; 2017 Sep; 47(5):663-669. PubMed ID: 28955383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
    Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
    Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure.
    Kamo T; Akazawa H; Suda W; Saga-Kamo A; Shimizu Y; Yagi H; Liu Q; Nomura S; Naito AT; Takeda N; Harada M; Toko H; Kumagai H; Ikeda Y; Takimoto E; Suzuki JI; Honda K; Morita H; Hattori M; Komuro I
    PLoS One; 2017; 12(3):e0174099. PubMed ID: 28328981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiota and cardiovascular diseases axis.
    Moldovan DC; Ismaiel A; Fagoonee S; Pellicano R; Abenavoli L; Dumitrascu DL
    Minerva Med; 2022 Feb; 113(1):189-199. PubMed ID: 33969961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiota and integrative traditional Chinese and western medicine in prevention and treatment of heart failure.
    Cui H; Han S; Dai Y; Xie W; Zheng R; Sun Y; Xia X; Deng X; Cao Y; Zhang M; Shang H
    Phytomedicine; 2023 Aug; 117():154885. PubMed ID: 37302262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut dysbiosis and heart failure: navigating the universe within.
    Madan S; Mehra MR
    Eur J Heart Fail; 2020 Apr; 22(4):629-637. PubMed ID: 32168550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship.
    Nesci A; Carnuccio C; Ruggieri V; D'Alessandro A; Di Giorgio A; Santoro L; Gasbarrini A; Santoliquido A; Ponziani FR
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interplay between diet, the gut microbiome, and atherosclerosis: Role of dysbiosis and microbial metabolites on inflammation and disordered lipid metabolism.
    Anto L; Blesso CN
    J Nutr Biochem; 2022 Jul; 105():108991. PubMed ID: 35331903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.